Wolfgang Kehr

Wolfgang Kehr has extensive work experience in the research and development sector. Wolfgang served as the CEO and shareholder of epinamics GmbH, a Berlin-based company specializing in drug delivery technology for cosmetic, pharmaceutical, and veterinary products. Wolfgang was responsible for leading the company and overseeing the development of their innovative Liqui-Patch platform technology. Wolfgang also worked as a partner and shareholder at Thanares GmbH, a Potsdam-based company focused on phytochemicals research and development. In this role, they contributed to the development of analytical methods for determining polyphenols and their metabolites, as well as studying the mechanism of action of phytochemicals with health-promoting properties. Prior to these roles, they served as the President and Managing Director of Intendis from 2004 to 2007. Details about their earlier work experience are not provided.

Wolfgang Kehr completed their Doctor of Medicine (M.D.) degree at The University of Göttingen in 1970. Wolfgang then pursued a Medical Specialist - Pharmacology certification at the Medical Association Berlin, which they completed in 1978. Later, they obtained an Extraordinary Professorship in Pharmacology from Freie Universität Berlin in 1986.